Financials

  • Market Capitalization 151.55 M
  • Employee 14
  • Founded 2017
  • CEO N/A
  • Website www.equilliumbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00LSL8C10
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-35.56
市销率
-3 628.01

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3744
NRXP
NRX Pharmaceuticals, Inc. - Common Stock
3.55 USD-1.93%-0.28%+12.70%+99.44%153.70 M USD
3748
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.14 USD-1.72%-8.06%-13.64%-40.00%151.90 M USD
3767
UNCY
Unicycive Therapeutics, Inc. - Common Stock
5.27 USD-4.18%-6.56%+5.40%-19.05%146.80 M USD
3772
ADCT
ADC Therapeutics SA Common Shares
1.14 USD+1.79%+14.00%+6.54%-63.11%145.54 M USD

新闻